EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking nitrogen compounds’ promise against malaria: A comprehensive review

Pranali Vijaykumar Kuthe, Mohammad Muzaffar-Ur-Rehman, Ala Chandu, Kirad Shivani Prashant, Murugesan Sankarnarayanan

Archiv der Pharmazie · 2024-09 · 357 (9)

DOI: 10.1002/ardp.202400222 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 04.06.2024. Verfasst von Pranali Vijaykumar Kuthe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, …. Hauptthemen laut MEDLINE: Antimalarials, Malaria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: DBT-BUILDER OPEX 06/03/0333.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium parasites are the primary cause of malaria, leading to high mortality rates, which require clinical attention. Many of the medications used in the treatment have resulted in resistance over time. Artemisinin combination therapy (ACT) has shown significant results for the treatment. However, mutations in the parasite have resulted in resistance, leading to decreased efficiency of the medications that are currently being used. Therefore, there is a critical need to find novel scaffolds that are safe, effective, and of economic advantage. Literature has reported several potent molecules with diverse scaffolds designed, synthesized, and evaluated against different strains of Plasmodium . With this growing list of compounds, it is essential to collect the data in one place to gain a concise overview of the emerging scaffolds in recent years. For this purpose, nitrogen‐containing heterocycles such as β‐carboline, imidazole, quinazoline, quinoline, thiazole, and thiophene have been highly explored due to their wide biological applications. Besides these, another scaffold, benzodiazepine, which is majorly used as a central nervous system depressant, is emerging as an anti‐malarial agent. Hence, this review centers on the latest medication advancements designed to combat malaria, emphasizing special attention to 1,4‐benzodiazepines as a novel scaffold for antimalarial drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaHumansNitrogen CompoundsPlasmodiumAnimalsDrug DiscoveryDrug ResistanceStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

Plasmodiumantimalarial agentsartemisinin combination therapy (ACT)malarianitrogen‐containing heterocycles

Substanzen

AntimalarialsNitrogen Compounds

Autor:innen und Institutionen

  • Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, India.

Förderung

  • DBT-BUILDER OPEX 06/03/0333

Zitieren

APA

Kuthe, P. V., Muzaffar-Ur-Rehman, M., Chandu, A., Prashant, K. S., & Sankarnarayanan, M. (2024). Unlocking nitrogen compounds’ promise against malaria: A comprehensive review. Archiv der Pharmazie, 357(9). https://doi.org/10.1002/ardp.202400222

Vancouver

Kuthe PV, Muzaffar-Ur-Rehman M, Chandu A, Prashant KS, Sankarnarayanan M. Unlocking nitrogen compounds’ promise against malaria: A comprehensive review. Archiv der Pharmazie. 2024;357(9). doi:10.1002/ardp.202400222

BibTeX
@article{Kuthe2024,
  author = {Kuthe, Pranali Vijaykumar and Muzaffar-Ur-Rehman, Mohammad and Chandu, Ala and Prashant, Kirad Shivani and Sankarnarayanan, Murugesan},
  title = {Unlocking nitrogen compounds’ promise against malaria: A comprehensive review},
  journal = {Archiv der Pharmazie},
  year = {2024},
  volume = {357},
  number = {9},
  doi = {10.1002/ardp.202400222}
}
Kostenlos starten →